4CPS-036 Is our protocol for the use of tocilizumab in COVID patients adequate? | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

Section 7: Post Congress additions

4CPS-036 Is our protocol for the use of tocilizumab in COVID patients adequate?

Free

Authors

A Dominguez Barahona Hospital Virgen de la Salud, Hospitalary Pharmacy, Toledo, Spain PubMed articles Google scholar articles
S Gonzalez Suárez Hospital Virgen de la Salud, Hospitalary Pharmacy, Toledo, Spain PubMed articles Google scholar articles
MA Toledo Davia Hospital Virgen de la Salud, Hospitalary Pharmacy, Toledo, Spain PubMed articles Google scholar articles
C Blazquez Romero Hospital Virgen de la Salud, Hospitalary Pharmacy, Toledo, Spain PubMed articles Google scholar articles
L Torralba Fernandez Hospital Virgen de la Salud, Hospitalary Pharmacy, Toledo, Spain PubMed articles Google scholar articles
R Lopez Alvarez Hospital Virgen de la Salud, Hospitalary Pharmacy, Toledo, Spain PubMed articles Google scholar articles
C Jimenez Mendez Hospital Virgen de la Salud, Hospitalary Pharmacy, Toledo, Spain PubMed articles Google scholar articles
P Moya Gomez Hospital Virgen de la Salud, Hospitalary Pharmacy, Toledo, Spain PubMed articles Google scholar articles

Citation

Dominguez Barahona A, Gonzalez Suárez S, Toledo Davia M, et al

4CPS-036 Is our protocol for the use of tocilizumab in COVID patients adequate?

European Journal of Hospital Pharmacy 2022;29:A183-A184.

Publication history

First published April 22, 2022.

Online issue publication

April 22, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.